ResearcherThe Cancer Institute HospitalNo recent work listed

Kumi Takagi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111264464. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper

Papers 1

Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. Co-author DOI 10.5582/bst.2023.01209 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshihiro Ono · 1 shared paper, 2023 · strength 0.18
- Paper Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. DOI 10.5582/bst.2023.01209 ↗
Yosuke Inoue · 1 shared paper, 2023 · strength 0.18
- Paper Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. DOI 10.5582/bst.2023.01209 ↗
Atsushi Oba · 1 shared paper, 2023 · strength 0.18
- Paper Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. DOI 10.5582/bst.2023.01209 ↗
Hiromichi Ito · 1 shared paper, 2023 · strength 0.18
- Paper Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. DOI 10.5582/bst.2023.01209 ↗
Yu Takahashi · 1 shared paper, 2023 · strength 0.18
- Paper Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. DOI 10.5582/bst.2023.01209 ↗
Akio Saiura · 1 shared paper, 2023 · strength 0.18
- Paper Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. DOI 10.5582/bst.2023.01209 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.